88
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO

, , , , , , , & show all
Pages 1227-1237 | Published online: 06 Mar 2012

References

  • JeschkeMGChinkesDLFinnertyCCPathophysiologic response to severe burn injuryAnn Surg200824838740118791359
  • AvniTLevcovichAAd-ElDDLeiboviciLPaulMProphylactic antibiotics for burns patients: systematic review and meta-analysisBMJ2010340c24120156911
  • GaleanoMAltavillaDCucinottaDRecombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouseDiabetes2004532509251715331568
  • SorgHKruegerCSchulzTMengerMDSchmitzFVollmarBEffects of erythropoietin in skin wound healing are dose relatedFASEB J2009233049305819403513
  • HamedSUllmannYMasoudMHellouEKhamaysiZTeotLTopical erythropoietin promotes wound repair in diabetic ratsJ Invest Dermatol201013028729419626038
  • BaderALorenzKRichterAInteractive role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic woundsRejuvenation Res201114576621329452
  • ParganasEWangDStravopodisDJak2 is essential for signalling through a variety of cytokine receptorsCell1998933853959590173
  • BodóEKrommingaAFunkWHuman hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietinFASEB J2007213346335417540710
  • JelkmannWMolecular biology of erythropoietinIntern Med2004864965915468961
  • BrinesMGrassoGFiordalisoFErythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptorProc Natl Acad Sci U S A2004101149071491215456912
  • BrinesMCeramiAErythropoietin mediated tissue protection: reducing collateral damage from the primary injury responseJ Intern Med200826440543219017170
  • JelkmannWBohliusJHallekMSytkowskiAJThe erythropoietin receptor in normal and cancer tissuesCrit Rev Oncol Hematol200867396118434185
  • ScottCLRobbLPapaevangeliouBMansfieldRNicolaNABegleyCGReassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony stimulating factor, or stem cell factorBlood2000961588159010942411
  • LeBaronMJAhonenTJNevalainenMTRuiHIn vivo response-based identification of direct hormone target cell populations using high-density tissue arraysEndocrinology2007148989100817138649
  • GaleanoMAltavillaDBittoARecombinant human erythropoietin improves angiogenesis and wound healing in experimental burn woundsCrit Care Med2006341139114616484928
  • SaqibNDulinLKrierKHowdieshellTRTemporal and spatial expression of erythropoietin, erythropoietin receptor, and common β receptor in wound fluid and granulationWounds2009217
  • LorenzKSickerMSchmelzerEMultilineage differentiation potential of human dermal skin-derived fibroblastsExp Dermatol20081192593218557932
  • HerndonDNHawkinsHKNguyenTTPierreECoxRBarrowRECharacterization of growth hormone enhanced donor site healing in patients with large cutaneous burnsAnn Surg19952216496567794069
  • ElliottSBusseLBassMBAnti-Epo receptor antibodies do not predict Epo receptor expressionBlood20061071892189516249375
  • PausRBodóEKrommingaAJelkmannWErythropoietin and the skin: a role for epidermal oxygen sensingBioessays20093134434819260015
  • CohanRAMadadkar-SobhaniAKhanahmadHDesign, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietinInt J Nanomedicine201161217122721753873
  • CheethamJCSmithDMAokiKHNMR structure of human erythropoietin and a comparison with its receptor bound conformationNat Struct Biol199858618669783743
  • WangTHuYLeachMKErythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalaciaInt J Pharm201242246247122101293
  • KhachanePDateAANagarsenkerMSEudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administrationJ Biomed Nanotechnol2011759059721870464